Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
gamma-linolenic acid
- Development stage
- Phase 4
- Lead developer
- Bioriginal
- Modality
- Small Molecules
- Administration
- Oral, Topical
01
Overview
Gamma-linolenic acid (GLA) is an omega-6 fatty acid found in plant seed oils like borage oil and evening primrose oil. It is used as a dietary supplement for various health benefits, including reducing symptoms of diabetic neuropathy and potentially aiding in cardiovascular health. GLA influences inflammatory processes by affecting prostaglandin and leukotriene production.
- Brand names
- EfamolEpogam
- Other names
- GLAGamolenic acidGammalinolenic acid(6Z,9Z,12Z)-Octadeca-6,9,12-trienoic acid
02
Targets
PTGS2 (Prostaglandin-Endoperoxide Synthase 2)PGHS-1 (Prostaglandin G/H Synthase 1)
Beyond the preview
Go deeper on gamma-linolenic acid.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on gamma-linolenic acid.